|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1993-9-21
|
|
pubmed:abstractText |
Malignant fibrous histiocytoma of bone (MFHB) is a rare tumour with a 3 year survival of 30%-40% when treated with surgery alone. A small number of patients have previously been treated with pre-operative chemotherapy and responses observed. The aim of the present study was to further determine the response of MFHB to pre-operative chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-15
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8394734-Adolescent,
pubmed-meshheading:8394734-Adult,
pubmed-meshheading:8394734-Aged,
pubmed-meshheading:8394734-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8394734-Bone Neoplasms,
pubmed-meshheading:8394734-Chemotherapy, Adjuvant,
pubmed-meshheading:8394734-Female,
pubmed-meshheading:8394734-Histiocytoma, Benign Fibrous,
pubmed-meshheading:8394734-Humans,
pubmed-meshheading:8394734-Male,
pubmed-meshheading:8394734-Middle Aged,
pubmed-meshheading:8394734-Preoperative Care,
pubmed-meshheading:8394734-Retrospective Studies
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Chemotherapy of malignant fibrous histiocytoma of bone.
|
|
pubmed:affiliation |
Department of Oncology, UCL Medical School, London, U.K.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
